Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: A Record linkage case-control study

BMJ

Volumn 311, Issue 6996, 1995, Pages 22-

  Evans, J M M ^a   McMahon, A D ^a   McGilchrist, M M ^a   White, G ^a   Murray, F E ^a   McDevitt, D G ^a   Macdonald, T M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DATA BASE; DIGESTIVE SYSTEM HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; TOPICAL DRUG ADMINISTRATION; ULCER PERFORATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMAN; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGE; ODDS RATIO; PATIENT ADMISSION; PEPTIC ULCER HEMORRHAGE; PEPTIC ULCER PERFORATION; RISK; STOMACH ULCER; SUPPORT, NON-U.S. GOV'T;

EID: 0029052991     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.311.6996.22     Document Type: Article

References (13)

1. Hawkey CJ. Non-steroidal anti-inflammatory drugs and peptic ulcers. Facts and figures multiply, but do they add up? BMJ 1990; 300: 278–84.
2. Bollini P Garcia-Rodriguez LA Perez Guthan S Walker AM. The impact of research quality and study design on epidemiologic studies of the effects of non-steroidal anti-inflammatory drugs on upper gastro-intestinal tract disease. Arch Intern Med 1992; 152: 1289–95.
3. Garcia-Rodriguez LA Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769–72.
4. Langman MJS Weil J Wainwright P Lawson DH Rawlins MD Logan RFA, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075–8.
5. Wood SM Coulson R. Adverse drug reactions on-line information tracking (ADROIT). Pharmaceutical Medicine 1993; 7: 203–13.
6. Newbery R Shuttleworth P Rapier C. A multicentre postmarketing surveillance study to evaluate the safety and efficacy of felbinac 3% gel in the treatment of musculoskeletal disorders in general practice. European Journal of Clinical Research 1992; 3: 139–50.
7. MacDonald TM McDevitt DG. The Tayside medicines monitoring unit (MEMO). In: StromBLed. Pharmacoepidemiology. 2nd ed. Chichester: Wiley, 1994: 245–55.
8. SAS Institute. SAS technical report P-217 SAS/STAT software: the PHREG procedure. Cary, North Carolina: SAS Institute, 1991.
9. Breslow NE Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. Lyons: International Agency for Research on Cancer, 1980. (IARC Scientific Publications No 32.)
10. Dean AD Dean JA Burton JH Dicker RC. Epi-Info: a data processing, database and statistics program for epidemiology on micro-computers. Atlanta, GA: Centers for Disease Control, Epidemiology Program Office, 1990.
11. Kohli HS Knill-Jones RP. How accurate are SMR1 (Scottish morbidity record 1) data? Health Bull (Edinb) 1992; 50: 14–23.
12. Kleinbaum DG Kupper LL Morgenstern H. Epidemiologic research. New York: Van Nostrand Reinhold, 1982: 223.
13. Beardon PHG McGilchrist MM McKendrick AD McDevitt DG MacDonald TM. Primary non-compliance with prescribed medication in primary care. BMJ 1993; 307: 846–8.